Literature DB >> 29169890

Differences between vaccinated and unvaccinated women explain increase in non-vaccine-type human papillomavirus in unvaccinated women after vaccine introduction.

Lili Ding1, Lea E Widdice2, Jessica A Kahn2.   

Abstract

The aim of this study was to determine whether an observed increase in non-vaccine-type human papillomavirus (HPV) in unvaccinated women during the first eight years after vaccine introduction may be explained by differences in demographics or sexual behaviors, instead of type replacement. We analyzed data from three cross-sectional surveillance studies of 13-26 year-old women (total N = 1180). For women recruited from a health department clinic, older age (OR = 1.4, 95% CI: 1.2-1.6) and consistent condom use with main partner in the past 3 months (OR = 11.6, 95% CI: 3.4-40) were associated with being unvaccinated. For women recruited from a teen health center African American race (OR = 0.2, 95% CI: 0.07-0.7) and having Medicaid health insurance (OR = 0.3, 95% CI: 0.1-0.7) were inversely associated with being unvaccinated. The observed increase in non-vaccine-type HPV prevalence in unvaccinated women may be explained by differences between unvaccinated and vaccinated women.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Human papillomavirus; Vaccine; Women

Mesh:

Substances:

Year:  2017        PMID: 29169890      PMCID: PMC5712261          DOI: 10.1016/j.vaccine.2017.11.005

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Health and Access to Care during the First 2 Years of the ACA Medicaid Expansions.

Authors:  Sarah Miller; Laura R Wherry
Journal:  N Engl J Med       Date:  2017-03-09       Impact factor: 91.245

3.  Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials.

Authors:  Joseph E Tota; Frank Struyf; Marko Merikukka; Paula Gonzalez; Aimée R Kreimer; Dan Bi; Xavier Castellsagué; Newton S de Carvalho; Suzanne M Garland; Diane M Harper; Naveen Karkada; Klaus Peters; Willy A J Pope; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mark Schiffman; John Schussler; S Rachel Skinner; Júlio Cesar Teixeira; Cosette M Wheeler; Rolando Herrero; Allan Hildesheim; Matti Lehtinen
Journal:  J Natl Cancer Inst       Date:  2017-01-28       Impact factor: 13.506

4.  Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women.

Authors:  Tasneem Shikary; David I Bernstein; Yan Jin; Gregory D Zimet; Susan L Rosenthal; Jessica A Kahn
Journal:  J Clin Virol       Date:  2009-08-08       Impact factor: 3.168

5.  Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006.

Authors:  Susan Hariri; Elizabeth R Unger; Maya Sternberg; Eileen F Dunne; David Swan; Sonya Patel; Lauri E Markowitz
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

6.  Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97.

Authors:  Zigui Chen; Rob DeSalle; Mark Schiffman; Rolando Herrero; Robert D Burk
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

7.  Sociodemographic factors associated with high-risk human papillomavirus infection.

Authors:  Jessica A Kahn; Dongmei Lan; Robert S Kahn
Journal:  Obstet Gynecol       Date:  2007-07       Impact factor: 7.661

8.  Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.

Authors:  Joseph E Tota; Mengzhu Jiang; Agnihotram V Ramanakumar; Stephen D Walter; Jay S Kaufman; François Coutlée; Harriet Richardson; Ann N Burchell; Anita Koushik; Marie Hélène Mayrand; Luisa L Villa; Eduardo L Franco
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

Review 9.  Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.

Authors:  David Mesher; Kate Soldan; Matti Lehtinen; Simon Beddows; Marc Brisson; Julia M L Brotherton; Eric P F Chow; Teresa Cummings; Mélanie Drolet; Christopher K Fairley; Suzanne M Garland; Jessica A Kahn; Kimberley Kavanagh; Lauri Markowitz; Kevin G Pollock; Anna Söderlund-Strand; Pam Sonnenberg; Sepehr N Tabrizi; Clare Tanton; Elizabeth Unger; Sara L Thomas
Journal:  Emerg Infect Dis       Date:  2016-10       Impact factor: 6.883

10.  Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types.

Authors:  K Kavanagh; K G J Pollock; A Potts; J Love; K Cuschieri; H Cubie; C Robertson; M Donaghy
Journal:  Br J Cancer       Date:  2014-04-15       Impact factor: 7.640

View more
  5 in total

1.  Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.

Authors:  Chelse Spinner; Lili Ding; David I Bernstein; Darron R Brown; Eduardo L Franco; Courtney Covert; Jessica A Kahn
Journal:  Pediatrics       Date:  2019-01-22       Impact factor: 7.124

Review 2.  Effect of human papillomavirus vaccination on sexual behaviour among young females.

Authors:  Robine Donken; Gina S Ogilvie; Julie A Bettinger; Manish Sadarangani; Ran D Goldman
Journal:  Can Fam Physician       Date:  2018-07       Impact factor: 3.275

3.  Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction.

Authors:  Lea E Widdice; David I Bernstein; Eduardo L Franco; Lili Ding; Darron R Brown; Aaron C Ermel; Lisa Higgins; Jessica A Kahn
Journal:  Vaccine       Date:  2019-09-30       Impact factor: 3.641

4.  Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.

Authors:  Andreas Ährlund-Richter; Liqin Cheng; Yue O O Hu; Mikaela Svensson; Alexandra A L Pennhag; Ramona G Ursu; Linnea Haeggblom; Nathalie Grün; Torbjörn Ramqvist; Lars Engstrand; Tina Dalianis; Juan Du
Journal:  Front Cell Infect Microbiol       Date:  2019-03-20       Impact factor: 5.293

5.  Incidence and Types of Human Papillomavirus Infections in Adolescent Girls and Young Women Immunized With the Human Papillomavirus Vaccine.

Authors:  Nicolas F Schlecht; Angela Diaz; Anne Nucci-Sack; Kathleen Shyhalla; Viswanathan Shankar; Mary Guillot; Dominic Hollman; Howard D Strickler; Robert D Burk
Journal:  JAMA Netw Open       Date:  2021-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.